Invention Grant
US09562095B2 Method for treating tumors that possess the CCK-C receptor with the 3B9.1 monoclonal antibody
有权
用3B9.1单克隆抗体治疗具有CCK-C受体的肿瘤的方法
- Patent Title: Method for treating tumors that possess the CCK-C receptor with the 3B9.1 monoclonal antibody
- Patent Title (中): 用3B9.1单克隆抗体治疗具有CCK-C受体的肿瘤的方法
-
Application No.: US14474284Application Date: 2014-09-01
-
Publication No.: US09562095B2Publication Date: 2017-02-07
- Inventor: Jill P. Smith
- Applicant: Jill P. Smith
- Agent Laurence Weinberger
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; C07K16/30 ; A61K45/06 ; G01N33/574
Abstract:
Human pancreatic cancer cells possess a distinct plasma membrane CCK receptor variant that can be differentiated from the classic CCK-B receptor with selective monoclonal antibodies. Use of this receptor may be helpful in early detection or treatment of patients with pancreatic cancer.
Public/Granted literature
- US20160168246A1 Method For Treating Tumors That Possess The CCK-C Receptor With The 3B9.1 Monoclonal Antibody Public/Granted day:2016-06-16
Information query
